Status:
TERMINATED
L-Tyrosine Supplementation in Patients With Fibromyalgia
Lead Sponsor:
Icahn School of Medicine at Mount Sinai
Conditions:
Fibromyalgia
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Patients in the study, who have a diagnosis of fibromyalgia, will be randomly assigned to take the amino acid L-tyrosine or placebo (blank pill) for 3 weeks. They will fill out questionnaires about th...
Detailed Description
Fibromyalgia is a chronic pain syndrome with few treatment options available. The amino-acid L-tyrosine is the precursor for norepinephrine in the central nervous system (CNS). Norepinephrine in the C...
Eligibility Criteria
Inclusion
- Diagnosis of fibromyalgia
- Pain greater than 4/10
- Age greater than 18
Exclusion
- Pregnant
- Age less than 18
Key Trial Info
Start Date :
January 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2011
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT01219049
Start Date
January 1 2010
End Date
January 1 2011
Last Update
April 11 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mount Sinai School of Medicine
New York, New York, United States, 10029